Clinical role of positron emission tomography in oncology.
about
The sweet trap in tumors: aerobic glycolysis and potential targets for therapyValidation of functional imaging as a biomarker for radiation treatment responseTargeting the phosphoinositide 3-kinase pathway in cancerDynamic PET and Optical Imaging and Compartment Modeling using a Dual-labeled Cyclic RGD Peptide Probe.Prognostic value of pretreatment standardized uptake value of F-18-fluorodeoxyglucose PET in patients with gastric cancer: a meta-analysisGlucose deprivation elicits phenotypic plasticity via ZEB1-mediated expression of NNMT.Performance of 18F-fluorodesoxyglucose positron-emission tomography combined with low-dose computed tomography for cancer screening in patients with unprovoked venous thromboembolism.Towards molecular imaging of multiple sclerosis.18F-fluoro-deoxy-glucose positron emission tomography (18F-FDG-PET) for assessment of enteropathy-type T cell lymphoma.Comparative Oncology: Evaluation of 2-Deoxy-2-[18F]fluoro-D-glucose (FDG) Positron Emission Tomography/Computed Tomography (PET/CT) for the Staging of Dogs with Malignant Tumors.The relationship between brown adipose tissue activity and neoplastic status: an (18)F-FDG PET/CT study in the tropicsThe potential of positron-emission tomography to study anticancer-drug resistance.Evaluation of 18-F-fluoro-2-deoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) as a staging and monitoring tool for dogs with stage-2 splenic hemangiosarcoma - A pilot study.The contribution of PET/CT to improved patient management.Incidental colorectal polyps in positron emission tomography.Clinical Value of a One-Stop-Shop Low-Dose Lung Screening Combined with (18)F-FDG PET/CT for the Detection of Metastatic Lung Nodules from Colorectal CancerTargeting of VX2 rabbit liver tumor by selective delivery of 3-bromopyruvate: a biodistribution and survival study.Role and cost effectiveness of PET/CT in management of patients with cancer.Tumor glycolysis as a target for cancer therapy: progress and prospects.Kinetic modeling in PET imaging of hypoxia.Diagnostic performance and safety of NMK36 (trans-1-amino-3-[18F]fluorocyclobutanecarboxylic acid)-PET/CT in primary prostate cancer: multicenter Phase IIb clinical trial.Factors influencing [F-18] 2-fluoro-2-deoxy-D-glucose (F-18 FDG) uptake in melanoma cells: the role of proliferation rate, viability, glucose transporter expression and hexokinase activity.PET technology: current trends and future developments.An atypical sarcoidosis involvement in FDG PET/CT: A case report.Enzymatic synthesis of tryptamine and its halogen derivatives selectively labeled with hydrogen isotopes.(18)F-Fluorodeoxyglucose positron-emission tomography could have a prognostic role in patients with advanced hepatocellular carcinoma.Tubular adenoma of the common bile duct with uptake in (18)F-FDG PET: A case report.Clinical impact of 18F-FDG-PET/CT in the extra cardiac work-up of patients with infective endocarditis.Editorial: Cancer Metabolism: Molecular Targeting and Implications for Therapy.Segmental acquisition method for stationary objects in (18)F-fluorodeoxyglucose positron emission tomography tests.Preclinical dynamic 18F-FDG PET - tumor characterization and radiotherapy response assessment by kinetic compartment analysis.Circulating procalcitonin in aseptic carcinoma patients: a specificity study with (18)F-fluorodeoxyglucose positron-emission tomography/computed tomography as benchmark.A 3D MR-acquisition scheme for nonrigid bulk motion correction in simultaneous PET-MR.Amplitude-based optimal respiratory gating in positron emission tomography in patients with primary lung cancer.Investigation of realistic PET simulations incorporating tumor patient's specificity using anthropomorphic models: creation of an oncology database.Potential Utility of FDG PET-CT as a Non-invasive Tool for Monitoring Local Immune Responses.Targeting tumor glycolysis by a mitotropic agent.Dual energy CT attenuation correction methods for quantitative assessment of response to cancer therapy with PET/CT imaging.Gastric cancers with microsatellite instability exhibit high fluorodeoxyglucose uptake on positron emission tomography.Physiological ¹⁸F-FDG uptake by the spinal cord: is it a point of consideration for cancer patients?
P2860
Q26766079-A8DF0F29-5C25-4D95-B8F5-D90C11170C40Q26823165-426B7181-C3F8-4E36-880A-7DC03167827AQ29615809-81183DD8-0B84-4A86-86B1-3B9E8933CFC0Q30524330-1D7E5375-78A3-4CD4-9D96-F5454D9469F8Q33568519-1464E67C-9797-4D23-9117-6E1CDA37A6A6Q33688593-3467CA9F-2482-4F2D-80B0-D120B6360A05Q33751980-FDED7961-495F-403E-ADF0-F91FE787D6FDQ33787779-6A90157F-B333-413C-B4A9-02DC46E5F078Q35595395-D224B849-407C-472D-9EB5-3125B347A472Q35661959-1FC36ED6-AFB7-424A-867F-A85FABFE66D9Q35705106-4208F028-442A-41EC-8B3A-ADD1306F4729Q35788120-B902E764-E16F-42B1-81CB-98739BD5BF17Q36286330-DCA3CFE8-B01C-4AF1-8F12-C645CB2C24FBQ36371912-6396FA66-B145-4A7C-A03E-EED304B8007DQ36771794-A8A53261-5F49-4AF5-A6F5-0185777CAFACQ36910273-6879E44F-5550-48AF-AB27-023B022615ABQ37384240-9053956E-C0E4-4595-BCB6-1307A7BC515FQ37768682-26D8CE46-002E-4F1B-99DA-2E6AE4A346F9Q38168262-0EFA19B0-FAA7-4DB9-ABDB-5848079902E7Q38253648-AB20F9A6-3DF1-40B0-B7BF-D843C4CDEDAEQ38924532-3B449DB4-0BDF-4618-9E52-CE76B115F0FEQ40393387-3570099C-735A-46F4-949D-5E36C9EA3135Q40472851-01C01C69-42C0-492D-91E0-AF1EC2255FD3Q40575054-1F6D1A1F-2543-42D7-9884-C63ED4875C0FQ40679396-AA148691-73E1-44A2-99FC-550CA229D654Q41850280-6E1BEDE8-86FC-4F32-B553-DD7F1D548CE5Q41880189-57C5F32F-826C-4399-81ED-4510D2EAC635Q42220247-61F9A48C-5A27-4983-95A2-2E36143781A6Q42368454-102CD89A-2ED0-4393-AFC1-F0B6D0BE81CAQ42849022-09340287-7683-4BBC-98D4-9EFC3F406AA8Q42910924-2C038078-AE08-49A2-94B3-CB5DDAD7063BQ43074699-D9E99950-5938-4C2F-9E17-28CAC50FF86AQ45252887-FFA7D470-0C32-46D1-85C7-B665DC84087CQ45954854-FD212AC7-5432-48F6-AA12-8D8FD684A7FBQ46011504-2311D2E0-C56C-4F1F-B0A1-9BB29C46BA4BQ48306408-1E4934D0-ED4F-4BCE-8AE5-A88890DBDB00Q50929846-B5ACD000-9AAA-418A-9060-0BFB05B80179Q51156237-C8E7D870-FF13-4C36-8E77-0B008F4A09FBQ53157005-FAC637A4-B7E9-4C50-B630-51B59A8212C4Q53180282-931A569C-E765-43BA-965C-B5E54AC62899
P2860
Clinical role of positron emission tomography in oncology.
description
2001 nî lūn-bûn
@nan
2001 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի մարտին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Clinical role of positron emission tomography in oncology.
@ast
Clinical role of positron emission tomography in oncology.
@en
Clinical role of positron emission tomography in oncology.
@nl
type
label
Clinical role of positron emission tomography in oncology.
@ast
Clinical role of positron emission tomography in oncology.
@en
Clinical role of positron emission tomography in oncology.
@nl
prefLabel
Clinical role of positron emission tomography in oncology.
@ast
Clinical role of positron emission tomography in oncology.
@en
Clinical role of positron emission tomography in oncology.
@nl
P2093
P1433
P1476
Clinical role of positron emission tomography in oncology.
@en
P2093
P304
P356
10.1016/S1470-2045(00)00257-6
P577
2001-03-01T00:00:00Z